Hjem › Arbeidsgivere › Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.: H-1B-lønninger og sponsering
Neurocrine Biosciences, Inc. leverte inn 48 arbeidsbetingelseserklæringer for H-1B og relaterte visa i regnskapsårene 2023–2026; sertifisert: 47. Median tilbudt lønn: $121 722.
Sponser Neurocrine Biosciences, Inc. H-1B-visa?
Neurocrine Biosciences, Inc. leverte inn 48 arbeidsbetingelseserklæringer i regnskapsårene 2023–2026, den siste levert inn 17. jun. 2026. En LCA er første steg i en H-1B-søknad, så arbeidsgiveren har sponset eller forberedt sponsering av H-1B-arbeidere; det garanterer ikke sponsering for en bestemt jobb. Sjekk arbeidsgiverens egne stillingsannonser.
Lønninger etter stillingstittel
| Stilling | LCA-er | Medianlønn |
|---|---|---|
| Scientist, Medicinal Chemistry | 8 | $93 615 |
| Sr. Scientist, Product Development-Late Stage | 4 | $116 300 |
| Sr. Scientist – In Vitro Pharmacology | 2 | $125 000 |
| Principal Drug Safety Scientist | 2 | $125 700 |
| Scientist, Product Development, Late Stage | 1 | $90 480 |
| Senior Data Management Manager | 1 | $150 654 |
| Scientist, Product Development Operations | 1 | $118 600 |
| Principal Scientist, Analytical Development | 1 | $122 000 |
| Scientist, Chemical Development | 1 | $110 000 |
| Scientist, Antibody Engineering | 1 | $86 200 |
| Scientist, Biologics Research | 1 | $86 200 |
| Analyst, Systems | 1 | $86 200 |
| Senior Principal Scientist, Computational Chemistry | 1 | $150 700 |
| Senior Commercial Analytics Manager | 1 | $156 811 |
| Scientist, Biologics Lead Optimization | 1 | $112 000 |
| Senior Scientist, Analytical Development | 1 | $123 864 |
| Principal Analyst, Biopharmaceutical Statistical Programming | 1 | $146 224 |
| Manager, HEOR (Health Economics and Outcomes Research) | 1 | $135 720 |
| Senior Scientist, Analytical Development Stability | 1 | $108 701 |
| Scientist, Product Development | 1 | $88 130 |
| Sr. Scientist, Chemical Development | 1 | $124 654 |
| Senior Specialist, Analytical Development Stability | 1 | $108 701 |
| Principal Analyst, Statistical Programming | 1 | $141 856 |
| Principal Biostatistician | 1 | $141 856 |
| Sr. Patent Specialist | 1 | $136 300 |
| Sr. Specialist, R&D Strategic Operations | 1 | $116 355 |
| Senior Program Manager – Drug Development | 1 | $154 900 |
| Sr. Medical Director, MD | 1 | $301 100 |
| Sr. Scientist, Peptide/Bio-organic Chemistry | 1 | $121 722 |
| Senior Scientist, Product Development – Late Stage | 1 | $116 355 |
| Sr. Scientist, Neuroimmunology | 1 | $125 507 |
| Sr. Commercial Analytics Manager, Omnichannel | 1 | $158 100 |
| Sr. Scientist, Peptide Chemistry | 1 | $121 722 |
| Principal Scientist, Neuroimmunology | 1 | $130 800 |
| Sr. Data Management Manager | 1 | $180 502 |
| Sr. Analyst Financial | 1 | $113 880 |
Søknader etter regnskapsår
| Regnskapsår | LCA-er | Medianlønn |
|---|---|---|
| FY2023 | 8 | $107 675 |
| FY2024 | 9 | $112 000 |
| FY2025 | 15 | $124 259 |
| FY2026 | 16 | $121 722 |
Gjengs lønnsnivåer
Department of Labor setter fire gjengs lønnsnivåer for hvert yrke og område, fra nivå I (nyansatt) til nivå IV (fullt kompetent). Arbeidsgiveren velger nivået som samsvarer med jobbkravene.
Hvor jobbene er
Yrker
- Biochemists and Biophysicists13
- Chemists12
- Medical Scientists, Except Epidemiologists7
- Regulatory Affairs Specialists3
- Statisticians3
- Management Analysts2
- Chemical Engineers2
- Computer Systems Analysts1
- Data Scientists1
- Regulatory Affairs Managers1
Nyeste søknader
| Stilling | Grunnlønn | Sted | Sendt inn | Startdato | Status |
|---|---|---|---|---|---|
| Sr. Analyst Financial | $113 880–$155 500 Nivå III | San Diego, CA | 17. jun. 2026 | 1. okt. 2026 | Sertifisert |
| Sr. Data Management Manager | $180 502–$252 800 Nivå IV | San Diego, CA | 26. mai 2026 | 15. jun. 2026 | Sertifisert |
| Principal Scientist, Neuroimmunology | $130 800–$179 000 Nivå III | San Diego, CA | 21. mai 2026 | 1. okt. 2026 | Sertifisert |
| Sr. Scientist, Peptide Chemistry | $121 722–$177 400 Nivå IV | San Diego, CA | 5. mai 2026 | 1. okt. 2026 | Sertifisert |
| Scientist, Medicinal Chemistry | $102 482–$143 600 Nivå III | San Diego, CA | 4. mai 2026 | 1. okt. 2026 | Sertifisert |
| Scientist, Medicinal Chemistry | $102 482–$143 600 Nivå III | San Diego, CA | 4. mai 2026 | 1. okt. 2026 | Sertifisert |
| Sr. Scientist, Neuroimmunology | $125 507–$177 400 Nivå III | San Diego, CA | 4. mai 2026 | 1. okt. 2026 | Sertifisert |
| Sr. Commercial Analytics Manager, Omnichannel | $158 100–$252 800 Nivå IV | San Diego, CA | 4. mai 2026 | 15. mai 2026 | Sertifisert |
| Senior Scientist, Product Development – Late Stage | $116 355–$177 400 Nivå III | San Diego, CA | 14. apr. 2026 | 1. okt. 2026 | Sertifisert |
| Sr. Scientist, Peptide/Bio-organic Chemistry | $121 722–$177 400 Nivå IV | San Diego, CA | 13. apr. 2026 | 1. okt. 2026 | Sertifisert |
| Sr. Medical Director, MD | $301 100–$481 000 Nivå IV | San Diego, CA | 13. apr. 2026 | 1. okt. 2026 | Sertifisert |
| Senior Program Manager – Drug Development | $154 900–$247 700 Nivå IV | San Diego, CA | 5. des. 2025 | 2. jan. 2026 | Sertifisert |
| Sr. Scientist, Product Development-Late Stage | $108 600–$173 800 Nivå III | San Diego, CA | 2. des. 2025 | 2. jan. 2026 | Sertifisert |
| Sr. Scientist, Product Development-Late Stage | $108 600–$157 350 Nivå III | San Diego, CA | 18. nov. 2025 | 1. des. 2025 | Sertifisert |
| Principal Analyst, Statistical Programming | $141 856–$205 200 Nivå IV | San Diego, CA | 19. aug. 2025 | 1. sep. 2025 | Sertifisert |
| Principal Biostatistician | $141 856–$205 200 Nivå IV | San Diego, CA | 24. jul. 2025 | 28. jul. 2025 | Sertifisert, deretter trukket |
| Sr. Patent Specialist | $136 300–$217 900 Nivå III | San Diego, CA | 22. jul. 2025 | 4. aug. 2025 | Sertifisert |
| Sr. Specialist, R&D Strategic Operations | $116 355–$161 700 Nivå III | San Diego, CA | 21. jul. 2025 | 21. jul. 2025 | Sertifisert |
| Sr. Scientist, Chemical Development | $124 654–$173 800 Nivå III | San Diego, CA | 23. jun. 2025 | 30. jun. 2025 | Sertifisert |
| Scientist, Medicinal Chemistry | $88 130–$140 800 Nivå II | San Diego, CA | 5. mai 2025 | 1. okt. 2025 | Sertifisert |
| Senior Specialist, Analytical Development Stability | $108 701–$152 400 Nivå III | San Diego, CA | 26. mar. 2025 | 5. aug. 2025 | Sertifisert |
| Scientist, Product Development | $88 130–$140 800 Nivå II | San Diego, CA | 5. mar. 2025 | 11. jul. 2025 | Sertifisert |
| Senior Scientist, Analytical Development Stability | $108 701–$152 400 Nivå III | San Diego, CA | 14. feb. 2025 | 5. aug. 2025 | Sertifisert, deretter trukket |
| Senior Scientist, Analytical Development | $123 864–$170 300 Nivå III | San Diego, CA | 18. des. 2024 | 17. feb. 2025 | Sertifisert |
| Principal Drug Safety Scientist | $125 700–$201 100 Nivå IV | San Diego, CA | 16. des. 2024 | 6. jan. 2025 | Sertifisert |
| Principal Drug Safety Scientist | $125 700–$201 100 Nivå IV | San Diego, CA | 16. des. 2024 | 6. jan. 2025 | Trukket |
| Principal Analyst, Biopharmaceutical Statistical Programming | $146 224–$201 100 Nivå IV | San Diego, CA | 22. nov. 2024 | 2. des. 2024 | Sertifisert |
| Manager, HEOR (Health Economics and Outcomes Research) | $135 720–$182 250 Nivå II | San Diego, CA | 8. okt. 2024 | 15. okt. 2024 | Sertifisert |
| Senior Commercial Analytics Manager | $156 811–$220 850 Nivå IV | San Diego, CA | 21. aug. 2024 | 15. sep. 2024 | Sertifisert, deretter trukket |
| Scientist, Biologics Lead Optimization | $112 000–$138 000 Nivå II | San Diego, CA | 12. aug. 2024 | 1. sep. 2024 | Sertifisert |
| Scientist, Antibody Engineering | $86 200–$138 000 Nivå I | San Diego, CA | 22. apr. 2024 | 1. okt. 2024 | Sertifisert, deretter trukket |
| Scientist, Medicinal Chemistry | $100 859–$138 000 Nivå II | San Diego, CA | 22. apr. 2024 | 1. okt. 2024 | Sertifisert |
| Scientist, Biologics Research | $86 200–$138 000 Nivå I | San Diego, CA | 22. apr. 2024 | 1. okt. 2024 | Sertifisert |
| Analyst, Systems | $86 200–$138 000 Nivå I | San Diego, CA | 18. apr. 2024 | 1. okt. 2024 | Sertifisert, deretter trukket |
| Senior Principal Scientist, Computational Chemistry | $150 700–$241 100 Nivå IV | San Diego, CA | 17. apr. 2024 | 1. okt. 2024 | Sertifisert |
| Sr. Scientist, Product Development-Late Stage | $124 000–$170 300 Nivå III | San Diego, CA | 13. mar. 2024 | 15. jul. 2024 | Sertifisert |
| Sr. Scientist, Product Development-Late Stage | $124 000–$170 300 Nivå III | San Diego, CA | 28. feb. 2024 | 19. jul. 2024 | Sertifisert |
| Scientist, Chemical Development | $110 000–$138 000 Nivå III | San Diego, CA | 15. feb. 2024 | 26. jul. 2024 | Sertifisert |
| Principal Scientist, Analytical Development | $122 000–$195 000 Nivå IV | San Diego, CA | 27. nov. 2023 | 8. jan. 2024 | Sertifisert |
| Senior Data Management Manager | $150 654–$235 700 Nivå IV | San Diego, CA | 20. sep. 2023 | 20. nov. 2023 | Sertifisert |
| Scientist, Product Development Operations | $118 600–$165 200 Nivå III | San Diego, CA | 23. aug. 2023 | 22. feb. 2024 | Sertifisert |
| Scientist, Medicinal Chemistry | $90 480–$134 700 Nivå II | San Diego, CA | 4. mai 2023 | 1. okt. 2023 | Sertifisert |
| Scientist, Medicinal Chemistry | $90 480–$134 700 Nivå II | San Diego, CA | 4. mai 2023 | 1. okt. 2023 | Sertifisert |
| Scientist, Medicinal Chemistry | $90 480–$134 700 Nivå II | San Diego, CA | 4. mai 2023 | 1. okt. 2023 | Sertifisert, deretter trukket |
| Scientist, Product Development, Late Stage | $90 480–$134 700 Nivå II | San Diego, CA | 4. mai 2023 | 1. okt. 2023 | Sertifisert |
| Scientist, Medicinal Chemistry | $96 750–$134 700 Nivå II | San Diego, CA | 3. mar. 2023 | 1. mai 2023 | Sertifisert |
| Sr. Scientist – In Vitro Pharmacology | $125 000–$136 000 Nivå IV | San Diego, CA | 12. mai 2022 | 1. okt. 2022 | Sertifisert, deretter trukket |
| Sr. Scientist – In Vitro Pharmacology | $125 000–$136 000 E-3 · Nivå IV | San Diego, CA | 17. mar. 2022 | 20. mai 2022 | Sertifisert, deretter trukket |
Lønnene er nedre grense for lønnen som tilbys i hver søknad, omregnet til årsbeløp; statistikken bruker kun sertifiserte fulltids-søknader. En LCA er ikke et visumvedtak, og én LCA kan dekke flere stillinger. Kilde: U.S. Department of Labor, OFLC LCA Disclosure Data, regnskapsår 2023–2026 (siste vedtak 30. jun. 2026).